2022 Q1 Form 10-Q Financial Statement
#000156459022017843 Filed on May 04, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
Revenue | $66.05M | $46.66M |
YoY Change | 41.56% | 40.65% |
Cost Of Revenue | $17.10M | $9.250M |
YoY Change | 84.9% | 23.66% |
Gross Profit | $48.95M | $37.41M |
YoY Change | 30.84% | 45.6% |
Gross Profit Margin | 74.11% | 80.18% |
Selling, General & Admin | $48.49M | $32.42M |
YoY Change | 49.57% | 45.84% |
% of Gross Profit | 99.06% | 86.65% |
Research & Development | $20.94M | $13.54M |
YoY Change | 54.74% | 23.94% |
% of Gross Profit | 42.79% | 36.18% |
Depreciation & Amortization | $2.826M | $700.0K |
YoY Change | 303.71% | -22.22% |
% of Gross Profit | 5.77% | 1.87% |
Operating Expenses | $85.13M | $45.95M |
YoY Change | 85.25% | 38.62% |
Operating Profit | -$36.18M | -$8.542M |
YoY Change | 323.54% | 14.58% |
Interest Expense | -$587.0K | $10.00K |
YoY Change | -5970.0% | -98.69% |
% of Operating Profit | ||
Other Income/Expense, Net | -$156.0K | -$14.00K |
YoY Change | 1014.29% | -93.1% |
Pretax Income | -$36.92M | -$8.544M |
YoY Change | 332.14% | 113.28% |
Income Tax | $115.0K | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$37.04M | -$8.544M |
YoY Change | 333.49% | 112.38% |
Net Earnings / Revenue | -56.07% | -18.31% |
Basic Earnings Per Share | -$0.51 | |
Diluted Earnings Per Share | -$511.0K | -$122.4K |
COMMON SHARES | ||
Basic Shares Outstanding | 72.47M | 68.53M |
Diluted Shares Outstanding | 72.48M |
Balance Sheet
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $376.1M | $208.0M |
YoY Change | 80.82% | 530.3% |
Cash & Equivalents | $250.9M | $189.6M |
Short-Term Investments | $125.2M | $18.40M |
Other Short-Term Assets | $16.14M | $11.30M |
YoY Change | 42.81% | 18.95% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $41.00M | $26.10M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $433.2M | $245.4M |
YoY Change | 76.55% | 318.77% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $7.980M | $18.10M |
YoY Change | -55.91% | -14.62% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $6.710M | $5.400M |
YoY Change | 24.26% | 145.45% |
Total Long-Term Assets | $101.8M | $23.40M |
YoY Change | 334.91% | 0.0% |
TOTAL ASSETS | ||
Total Short-Term Assets | $433.2M | $245.4M |
Total Long-Term Assets | $101.8M | $23.40M |
Total Assets | $535.0M | $268.8M |
YoY Change | 99.04% | 227.8% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $7.924M | $4.700M |
YoY Change | 68.6% | -21.67% |
Accrued Expenses | $40.62M | $18.20M |
YoY Change | 123.18% | 61.06% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $64.81M | $40.10M |
YoY Change | 61.61% | 21.15% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $336.0M | $0.00 |
YoY Change | -100.0% | |
Other Long-Term Liabilities | $24.30M | $13.40M |
YoY Change | 81.37% | -14.65% |
Total Long-Term Liabilities | $336.0M | $13.40M |
YoY Change | 2407.65% | -84.27% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $64.81M | $40.10M |
Total Long-Term Liabilities | $336.0M | $13.40M |
Total Liabilities | $425.1M | $53.50M |
YoY Change | 694.64% | -54.78% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $109.9M | $215.3M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $535.0M | $268.8M |
YoY Change | 99.04% | 227.8% |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$37.04M | -$8.544M |
YoY Change | 333.49% | 112.38% |
Depreciation, Depletion And Amortization | $2.826M | $700.0K |
YoY Change | 303.71% | -22.22% |
Cash From Operating Activities | -$21.99M | -$12.76M |
YoY Change | 72.32% | 27.71% |
INVESTING ACTIVITIES | ||
Capital Expenditures | -$1.340M | -$480.0K |
YoY Change | 179.17% | -20.0% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$23.47M | -$18.37M |
YoY Change | 27.78% | |
Cash From Investing Activities | -$24.81M | -$18.85M |
YoY Change | 31.61% | 3058.12% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 184.0K | 1.741M |
YoY Change | -89.43% | -95.1% |
NET CHANGE | ||
Cash From Operating Activities | -21.99M | -12.76M |
Cash From Investing Activities | -24.81M | -18.85M |
Cash From Financing Activities | 184.0K | 1.741M |
Net Change In Cash | -46.61M | -29.87M |
YoY Change | 56.05% | -219.67% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$21.99M | -$12.76M |
Capital Expenditures | -$1.340M | -$480.0K |
Free Cash Flow | -$20.65M | -$12.28M |
YoY Change | 68.15% | 30.76% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | bigc |
First Contingent Compensation Arrangement Payments Over Service Period
FirstContingentCompensationArrangementPaymentsOverServicePeriod
|
P12M | |
CY2022Q1 | bigc |
First Contingent Compensation Arrangement Payments Over Service Period
FirstContingentCompensationArrangementPaymentsOverServicePeriod
|
P12M | |
CY2022Q1 | dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
2013-02-28 | |
CY2022Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P5Y2M12D | |
CY2021Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P5Y10M24D | |
CY2022Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1313000 | |
CY2021Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
726000 | |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
2502000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
3899000 | |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
806000 | |
CY2022Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
17103000 | |
CY2021Q1 | us-gaap |
Gross Profit
GrossProfit
|
37410000 | |
CY2022Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
12660000 | |
CY2022Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2037000 | |
CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
85126000 | |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-36179000 | |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8542000 | |
CY2021Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
12000 | |
CY2022Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-156000 | |
CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-14000 | |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-36922000 | |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-8544000 | |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
115000 | |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-37037000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8544000 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.51 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.12 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
72476000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
69792000 | |
CY2022Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-613000 | |
CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-37650000 | |
CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-8544000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
216759000 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1952000 | |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
5171000 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
215338000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
138288000 | |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
277000 | |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-613000 | |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
109877000 | |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-37037000 | |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-8544000 | |
CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2826000 | |
CY2021Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
706000 | |
CY2022Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
488000 | |
CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8962000 | |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5171000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-18854000 | |
CY2022Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
184000 | |
CY2021Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1741000 | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
184000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1741000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
190736000 | |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-46614000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-29871000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
298704000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
220607000 | |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
252090000 | |
CY2022Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
96000 | |
CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
250934000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
582000 | |
CY2022Q1 | bigc |
Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
|
658000 | |
CY2021Q1 | bigc |
Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
|
796000 | |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-287000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1130000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
190736000 | |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
189578000 | |
CY2022Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
1156000 | |
CY2021Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
1158000 | |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
252090000 | |
CY2022Q1 | bigc |
Increase Decrease In Accrued And Other Current Liabilities
IncreaseDecreaseInAccruedAndOtherCurrentLiabilities
|
5702000 | |
CY2021Q1 | bigc |
Increase Decrease In Accrued And Other Current Liabilities
IncreaseDecreaseInAccruedAndOtherCurrentLiabilities
|
-6399000 | |
CY2022Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
14000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
1989000 | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-21985000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-12758000 | |
CY2022Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
32473000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
18374000 | |
CY2022Q1 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
1340000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
480000 | |
CY2022Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
9000000 | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-24813000 | |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
472000 | |
CY2022Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
32000 | |
CY2021Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
13100000 | |
CY2022Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align:justify;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires certain financial instruments to be recorded at fair value; requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenue and expenses during the reporting periods. Significant estimates, judgments, and assumptions in these consolidated financial statements include: allocating variable consideration for revenue recognition; the amortization period for deferred commissions; the </p> <p style="text-align:justify;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of significant</span><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> accounting policies (continued)</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">allowance for credit losses; a determination of the deferred tax asset valuation allowance and the valuation of our common stock used to determine stock-based compensation expense prior to our IPO. Because of the use of estimates inherent in the financial reporting process and given the additional or unforeseen effects from the COVID-19 pandemic, actual results could differ from those estimates, and such differences could be material to our consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19, declared a global pandemic by the World Health Organization on March 11, 2020, has caused disruption to the economies and communities of the United States and our target international markets. In the interest of public health, many governments closed physical stores and places of business deemed non-essential. This precipitated a significant shift in shopping behavior from offline to online. Our business has benefited from this shift, both in accelerated sales growth for our existing customers’ stores, and in our sales of new store subscriptions to customers. Nevertheless, we do not have certainty that those trends will continue; the COVID-19 pandemic and the uncertainty it has created in the global economy could materially adversely affect our business, financial condition, and results of operations.</p> | |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
66050000 | |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
46660000 | |
CY2022Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7980000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7429000 | |
CY2022Q1 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
14000000.0 | |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
3867000 | |
CY2022Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1313000 | |
CY2022Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
637000 | |
CY2022Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
4543000 | |
CY2022Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
12700000 | |
CY2021 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
0.0 | |
CY2022Q1 | bigc |
Business Combination Acquisition Related Spend
BusinessCombinationAcquisitionRelatedSpend
|
300000 | |
CY2022Q1 | bigc |
Business Combination Compensation Expense Related To Contingent Compensation
BusinessCombinationCompensationExpenseRelatedToContingentCompensation
|
12400000 | |
CY2022Q1 | bigc |
Second Contingent Compensation Arrangement Payments Over Service Period
SecondContingentCompensationArrangementPaymentsOverServicePeriod
|
P24M | |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
66050000 | |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
46660000 | |
CY2022Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
7200000 | |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
153500000 | |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
|
We expect to recognize approximately 50% of the remaining performance obligations as revenue in the following 12-month period, and the remaining balance in the periods thereafter. | |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
|
0.50 | |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P12M | |
CY2022Q1 | bigc |
Amortization Of Deferred Sales Commissions Estimated Period
AmortizationOfDeferredSalesCommissionsEstimatedPeriod
|
P3Y | |
CY2022Q1 | bigc |
Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
|
0 | |
CY2021 | bigc |
Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
|
0 | |
CY2022Q1 | bigc |
Deferred Sales Commissions
DeferredSalesCommissions
|
1600000 | |
CY2021Q1 | bigc |
Deferred Sales Commissions
DeferredSalesCommissions
|
1500000 | |
CY2022Q1 | us-gaap |
Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
|
1100000 | |
CY2021Q1 | us-gaap |
Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
|
700000 | |
CY2022Q1 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
345538000 | |
CY2021Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
364994000 | |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
5384000 | |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
32995000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
38379000 | |
CY2021Q3 | bigc |
Business Combinations Existing Products And Financial Milestones
BusinessCombinationsExistingProductsAndFinancialMilestones
|
65000000.0 | |
CY2022Q1 | bigc |
Second Contingent Compensation Arrangement Payments Over Service Period
SecondContingentCompensationArrangementPaymentsOverServicePeriod
|
P24M | |
CY2022Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
CY2022Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2000000.0 | |
CY2021Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
0.0 | |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
38379000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
3347000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
35032000 | |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
5968000 | |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
7958000 | |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
7823000 | |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
6134000 | |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
3395000 | |
CY2022Q1 | bigc |
Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
|
1717000 | |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
32995000 | |
CY2022Q1 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
0 | |
CY2021Q4 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
0 | |
CY2022Q1 | bigc |
Lease Operating Lease Expiration Year
LeaseOperatingLeaseExpirationYear
|
2028 | |
CY2022Q1 | bigc |
Operating And Short Term Rent Expense
OperatingAndShortTermRentExpense
|
1400000 | |
CY2021Q1 | bigc |
Operating And Short Term Rent Expense
OperatingAndShortTermRentExpense
|
900000 | |
CY2022Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1326000 | |
CY2021Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
972000 | |
CY2022Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0541 | |
CY2021Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0546 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
2757000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
3258000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
2985000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
2775000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
2528000 | |
CY2022Q1 | bigc |
Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
|
2852000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
17155000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
2273000 | |
CY2022Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
14882000 | |
CY2022Q1 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
813000 | |
CY2021Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
679000 | |
CY2022Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
10795000 | |
CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
17315000 | |
CY2022Q1 | bigc |
Acquisition Related Compensation Current
AcquisitionRelatedCompensationCurrent
|
22559000 | |
CY2021Q4 | bigc |
Acquisition Related Compensation Current
AcquisitionRelatedCompensationCurrent
|
14309000 | |
CY2022Q1 | us-gaap |
Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
|
3043000 | |
CY2021Q4 | us-gaap |
Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
|
3951000 | |
CY2022Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
37210000 | |
CY2021Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
36254000 | |
CY2022Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
345000000 | |
CY2021Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
345000000 | |
CY2022Q1 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
8975000 | |
CY2021Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
9463000 | |
CY2022Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
336025000 | |
CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
335537000 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
876584 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
20.25 | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y1M6D | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.63 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.018 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2022Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
8962000 | |
CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5171000 | |
CY2022Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2022Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0031 | |
CY2021Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | |
CY2022Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
396000 | |
CY2021Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2022Q1 | us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
0 | |
CY2022Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
17955000 | |
CY2021Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9359000 |